SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$12.39
Tradestie Score
62
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
-19.3%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$9.84
|
$1.92B | - | 56 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$99.95
|
$1.92B | - | 55 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$78.17
|
$1.90B | 444.4 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$42.46
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.88
|
$1.81B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$7.38
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.94
|
$1.78B | - | 56 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.90
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$35.26
|
$1.68B | - | 60 | Compare |
|
MNKD
Mannkind Corporation
|
$4.14
|
$1.65B | - | 63 | Compare |
More SLS Analysis
Data updated: Jun 27, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry